CD8A and HIV infectious disease: Moreover, Zhen et al. reported that blocking IFNAR2 during the chronic phase of HIV infection led to decreased viral replication, diminished HIV-1-driven immune activation, and restored HIV-1 specific CD8+ T cell function [72].